STOCK TITAN

Bausch Health Announces Participation In Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Bausch Health Companies (NYSE/TSX: BHC) will participate in two upcoming investor conferences. CEO Joseph C. Papa and CFO Paul S. Herendeen will present at the Wolfe Virtual Healthcare Conference on Nov. 19, 2020, at 2:55 p.m. ET. Additionally, they will join the Evercore ISI HealthCONx Conference on Dec. 1, 2020, at 8:50 a.m. ET. Live webcasts and audio archives of these events will be accessible on the company's Investor Relations page. Bausch Health aims to enhance global health through its diverse range of healthcare products.

Positive
  • None.
Negative
  • None.

LAVAL, Quebec, Nov. 10, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that the Company will participate in two investor conferences.

Joseph C. Papa, chairman and chief executive officer, Sam Eldessouky, senior vice president and corporate controller, and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the Wolfe Virtual Healthcare Conference on Nov. 19, 2020 at 2:55 p.m. ET.

Paul S. Herendeen, executive vice president and chief financial officer, and Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, are scheduled to participate at the Evercore ISI HealthCONx Conference on Dec. 1, 2020 at 8:50 a.m. ET.

A live webcast and audio archive of the events will be available on the Investor Relations page of the Bausch Health Companies Inc. web site at: http://ir.bauschhealth.com/events-and-presentations/2020.

About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com.

Investor Contact:                                          

Media Contact:

Arthur Shannon                                               

Lainie Keller

arthur.shannon@bauschhealth.com                

lainie.keller@bauschhealth.com

(514) 856-3855                                                 

(908) 927-1198

(877) 281-6642 (toll free)


 

Bausch Health logo (PRNewsfoto/Bausch Health Companies Inc.)

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/bausch-health-announces-participation-in-upcoming-investor-conferences-301168928.html

SOURCE Bausch Health Companies Inc.

FAQ

What conferences will Bausch Health (BHC) participate in November 2020?

Bausch Health will participate in the Wolfe Virtual Healthcare Conference on Nov. 19, 2020.

When is Bausch Health's (BHC) presentation at the Evercore ISI HealthCONx Conference?

Bausch Health's presentation at the Evercore ISI HealthCONx Conference is scheduled for Dec. 1, 2020, at 8:50 a.m. ET.

Who will represent Bausch Health (BHC) at the investor conferences?

Joseph C. Papa, Paul S. Herendeen, and Arthur J. Shannon will represent Bausch Health at the conferences.

Where can I watch the live webcast of Bausch Health's (BHC) presentations?

The live webcast and audio archive of Bausch Health's presentations will be available on their Investor Relations page.

Bausch Health Companies Inc.

NYSE:BHC

BHC Rankings

BHC Latest News

BHC Stock Data

3.17B
367.80M
11.08%
77.48%
3.27%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
QUEBEC